Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CVRX
CVRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CVRX News
Pomerantz LLP Investigates CVRx for Securities Fraud
Mar 03 2026
Globenewswire
CVRx Unveils New Data on Barostim Therapy at THT 2026
Mar 02 2026
Newsfilter
Pomerantz LLP Investigates CVRx for Securities Fraud
Feb 24 2026
Globenewswire
Maplight and CVRx Executives Increase Stock Holdings
Feb 23 2026
NASDAQ.COM
Pomerantz LLP Investigates CVRx for Securities Fraud
Feb 20 2026
PRnewswire
CVRx Under Investigation for Possible Securities Law Violations
Feb 19 2026
Businesswire
CVRx Under Investigation for Possible Securities Law Violations
Feb 19 2026
Businesswire
CVRx Under Investigation for Possible Securities Law Violations
Feb 19 2026
Newsfilter
Pomerantz LLP Investigates CVRx for Securities Fraud
Feb 17 2026
Globenewswire
CVRx Q4 2025 Earnings Call Insights
Feb 13 2026
seekingalpha
CVRx Reports Q4 Earnings Beat with Revenue Growth
Feb 12 2026
seekingalpha
CVRx Under Investigation for Possible Securities Law Violations
Feb 11 2026
Businesswire
CVRx Faces Investor Lawsuit Investigation
Jan 30 2026
Globenewswire
CVRx Under Investigation for Potential Securities Violations
Jan 30 2026
Businesswire
Pomerantz LLP Investigates CVRx for Securities Fraud
Jan 27 2026
Globenewswire
CVRx Initiates Landmark BENEFIT-HF Trial with 2,500 Patient Enrollment Target
Jan 23 2026
Benzinga
Show More News
